BiotechTube

Tacrolimus immediate-release formulation + Tacrolimus prolonged-release formulation + Induction therapy + Mycophenolic acid drugs + Corticosteroids

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Kidney Transplant

Conditions

Kidney Transplant

Trial Timeline

Oct 21, 2018 → Jul 15, 2022

NCT ID
NCT03644485

About Tacrolimus immediate-release formulation + Tacrolimus prolonged-release formulation + Induction therapy + Mycophenolic acid drugs + Corticosteroids

Tacrolimus immediate-release formulation + Tacrolimus prolonged-release formulation + Induction therapy + Mycophenolic acid drugs + Corticosteroids is a approved stage product being developed by Astellas Pharma for Kidney Transplant. The current trial status is completed. This product is registered under clinical trial identifier NCT03644485. Target conditions include Kidney Transplant.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT03644485ApprovedCompleted

Competing Products

20 competing products in Kidney Transplant

See all competitors
ProductCompanyStageHype Score
Empagliflozin + Matching placeboEli LillyPhase 3
77
Baricitinib + PlaceboEli LillyPhase 2
52
SGLT2 inhibitorEli LillyPre-clinical
23
LY2623091 + EplerenoneEli LillyPhase 2
52
Telmisartan/Rosuvastatin 40/10mg + Telmisartan 40mgYuhanApproved
85
TacrolimusAstellas PharmaApproved
85
RituximabAstellas PharmaPhase 2
52
Prograf + MR4Astellas PharmaPhase 3
77
basiliximab + rabbit anti-thymocyte globulin + tacrolimus + alemtuzumab + mycophenolate mofetil + steroidsAstellas PharmaApproved
85
Tacrolimus, modified releaseAstellas PharmaPhase 3
77
Tacrolimus granulesAstellas PharmaApproved
85
roxadustatAstellas PharmaPhase 3
77
ASP1128 + PlaceboAstellas PharmaPhase 2
52
FK506MR + Prograf + Mycophenolate Mofetil + Methylprednisolone + PrednisoloneAstellas PharmaPhase 3
77
MMF (Cellcept) and Steroids + Tacrolimus (Prograf)Astellas PharmaApproved
85
ASP1585Astellas PharmaPhase 3
77
Alefacept + tacrolimus + basiliximab + mycophenolate mofetil + CorticosteroidsAstellas PharmaPhase 2
52
Advagraf + Mycophenolate Mofetil + Simulect + CorticosteroidsAstellas PharmaApproved
85
tacrolimusAstellas PharmaApproved
85
roxadustatAstellas PharmaPhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85